Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2015; Volume 43,Issue 8

Short Communications

  • You have access
    Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
    Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
    Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412
  • You have access
    Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
    Eunyoung Lee, Zhexue Wu, Jong Cheol Shon and Kwang-Hyeon Liu
    Drug Metabolism and Disposition August 2015, 43 (8) 1250-1253; DOI: https://doi.org/10.1124/dmd.115.064345

Symposium Report

  • You have access
    “Target-Site” Drug Metabolism and Transport
    Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
    Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

Articles

  • You have access
    Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
    Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
    Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139
  • You have access
    Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
    Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
    Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800
  • You have access
    Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
    Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
    Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610
  • You have access
    Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
    Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
    Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479
  • You have access
    Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase
    Takaya Kurokawa, Tatsuki Fukami and Miki Nakajima
    Drug Metabolism and Disposition August 2015, 43 (8) 1218-1225; DOI: https://doi.org/10.1124/dmd.115.064089
  • You have access
    The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
    Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
    Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428
  • You have access
    A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
    Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
    Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602
  • You have access
    Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol
    Hassan N. Althurwi, Zaid H. Maayah, Osama H. Elshenawy and Ayman O. S. El-Kadi
    Drug Metabolism and Disposition August 2015, 43 (8) 1254-1266; DOI: https://doi.org/10.1124/dmd.115.063776
  • You have access
    Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
    Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
    Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
  • You have access
    Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
    Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
    Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550
  • You have access
    Variability in Expression of CYP3A5 in Human Fetal Liver
    Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
    Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

Errata

  • You have access
    Correction to: “Activity Suppression Behavior Phenotype in SULT4A1 Frameshift Mutant Zebrafish”
    Drug Metabolism and Disposition August 2015, 43 (8) 1284; DOI: https://doi.org/10.1124/dmd.115.064485err
  • You have access
    Correction to: “Constitutive Androgen Receptor-Null Mice Are Sensitive to the Toxic Effects of Parathion: Association with Reduced Cytochrome P450-Mediated Parathion Metabolism”
    Drug Metabolism and Disposition August 2015, 43 (8) 1285; DOI: https://doi.org/10.1124/dmd.115.032961err
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 43 (8)
Drug Metabolism and Disposition
Vol. 43, Issue 8
1 Aug 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Symposium Report
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics